• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开发并维持一个用于传输既往放射治疗治疗细节的安全应用程序。

Developing and sustaining a secure application for transfer of previous radiation therapy treatment details.

作者信息

Thompson Kenton, Moloney Phillip, Cristofaro Nigel, Smith Drew, Davis Dominic, James Chris, Geddes Vaughan, Panettieri Vanessa

机构信息

Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.

Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria, Australia.

出版信息

Tech Innov Patient Support Radiat Oncol. 2025 Aug 8;35:100334. doi: 10.1016/j.tipsro.2025.100334. eCollection 2025 Sep.

DOI:10.1016/j.tipsro.2025.100334
PMID:40894077
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12391762/
Abstract

Data availability remains a major challenge for radiation therapy dose accumulation for patients' re-treatment and re-irradiation. When a patient moves between radiation therapy providers it is particularly challenging. To address this challenge, a solution was developed for departments in Victoria, Australia, with the ability to request and receive files of any size and type from other providers, supported by a workflow system, an independent security model and a highly secure platform. In the first 5 years there have been 3911 requests for previous treatment details. Of these 2937 (75 %) involved transfer of DICOM data to enable higher quality dose accumulation assessment.

摘要

数据可用性仍然是患者再治疗和再照射的放射治疗剂量累积面临的主要挑战。当患者在不同放射治疗机构之间转诊时,这一挑战尤为突出。为应对这一挑战,澳大利亚维多利亚州的各部门开发了一种解决方案,该方案能够在工作流系统、独立安全模型和高度安全平台的支持下,从其他机构请求并接收任何大小和类型的文件。在最初的5年里,共收到3911次对既往治疗细节的请求。其中,2937次(75%)涉及DICOM数据的传输,以实现更高质量的剂量累积评估。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15da/12391762/391d4650d4ad/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15da/12391762/3f4048307c7f/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15da/12391762/35fde9459ad5/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15da/12391762/1223f1fdf374/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15da/12391762/391d4650d4ad/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15da/12391762/3f4048307c7f/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15da/12391762/35fde9459ad5/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15da/12391762/1223f1fdf374/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15da/12391762/391d4650d4ad/gr4.jpg

相似文献

1
Developing and sustaining a secure application for transfer of previous radiation therapy treatment details.开发并维持一个用于传输既往放射治疗治疗细节的安全应用程序。
Tech Innov Patient Support Radiat Oncol. 2025 Aug 8;35:100334. doi: 10.1016/j.tipsro.2025.100334. eCollection 2025 Sep.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.
4
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
5
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
6
Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.吸入装置在哮喘和慢性阻塞性气道疾病中的有效性比较:文献系统评价
Health Technol Assess. 2001;5(26):1-149. doi: 10.3310/hta5260.
7
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
8
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.静脉注射硫酸镁和索他洛尔预防冠状动脉搭桥术后房颤:系统评价与经济学评估
Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280.
9
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
10
Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion-dependent thalassaemia.甲磺酸去铁胺用于治疗依赖输血的地中海贫血患者的输血性铁过载。
Cochrane Database Syst Rev. 2013 Aug 21;2013(8):CD004450. doi: 10.1002/14651858.CD004450.pub3.

本文引用的文献

1
Reirradiation - still navigating uncharted waters?再程放疗——仍在未知水域中航行?
Clin Transl Radiat Oncol. 2024 Oct 2;49:100871. doi: 10.1016/j.ctro.2024.100871. eCollection 2024 Nov.
2
European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus on re-irradiation: definition, reporting, and clinical decision making.欧洲放射肿瘤学会和欧洲癌症研究与治疗组织关于再放疗的共识:定义、报告和临床决策。
Lancet Oncol. 2022 Oct;23(10):e469-e478. doi: 10.1016/S1470-2045(22)00447-8.
3
The Special Medical Physics Consult Process for Reirradiation Patients.
再照射患者的特殊医学物理会诊流程
Adv Radiat Oncol. 2019 Jun 8;4(4):559-565. doi: 10.1016/j.adro.2019.05.007. eCollection 2019 Oct-Dec.